Early identification of cardiovascular involvement in patients with β-thalassemia major

Maurizio Cusmà Piccione1, Basilia Piraino, Concetta Zito

  • 1Clinical and Experimental Department of Medicine, University of Messina, Messina, Italy.

Insights

Early cardiovascular changes occur in patients with beta-thalassemia major (β-TM), even without significant iron overload. Two-dimensional strain and echo-tracking effectively detect these subclinical abnormalities, surpassing standard echocardiography.

Area of Science:

  • Cardiology
  • Hematology
  • Medical Imaging

Background:

  • Beta-thalassemia major (β-TM) is a genetic blood disorder requiring lifelong transfusions.
  • Cardiovascular complications, including myocardial iron overload, are a major concern in β-TM patients.
  • Early detection of subclinical cardiovascular abnormalities is crucial for timely intervention.

Purpose of the Study:

  • To assess subclinical left ventricular myocardial deformation and carotid arterial stiffness in asymptomatic β-TM patients.
  • To determine if 2-dimensional strain and echo-tracking can identify early cardiovascular changes in β-TM.
  • To evaluate these parameters in the absence of significant myocardial iron overload.

Main Methods:

  • 32 β-TM patients and 33 healthy controls underwent 2-dimensional strain analysis (XStrain) and carotid ultrasonography.
  • Cardiac magnetic resonance imaging (T2* algorithm) assessed myocardial iron overload in patients.
  • Echocardiography and vascular stiffness parameters were measured and compared between groups.

Main Results:

  • Global left ventricular longitudinal strain was significantly impaired in β-TM patients (-17.9% vs -24.3%, p=0.002).
  • Arterial stiffness was significantly increased in β-TM patients (stiffness index 6.16 vs 4.65, p<0.001).
  • Standard echocardiographic and carotid intima-media thickness were comparable between groups.

Conclusions:

  • Cardiovascular abnormalities, including impaired myocardial strain and increased arterial stiffness, are present early in β-TM, even without significant iron overload.
  • Two-dimensional strain and echo-tracking are more sensitive than standard echocardiography and vascular parameters for early detection of cardiovascular involvement in β-TM.
  • These advanced imaging techniques may aid in identifying at-risk patients and guiding therapeutic strategies.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Assessment of the Cardiovascular System II: Inspection01:29

Assessment of the Cardiovascular System II: Inspection

Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
Head and Neck
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Cardiovascular System Abnormal Findings I: Inspection and Palpation01:29

Cardiovascular System Abnormal Findings I: Inspection and Palpation

In a cardiovascular examination, inspection and palpation are crucial for identifying abnormalities.
Abnormal findings observed during an inspection
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...